Rozanolixizumab; Solution for subcutaneous infusion 280 mg in 2 mL (140 mg per mL); Rystiggo® Page last updated: 3 September 2025 Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF 949KB) Public Summary Document (PSD) March 2025 PBAC Meeting - (Word 443KB)